Search

Campbell, Kirsti A, Scot B Sternberg, James Benneyan, Sarah N Flier, Maelys Amat, Talya Salant, Keishi Nambara, et al. 2024. “Completion Rates and Timeliness of Diagnostic Colonoscopies for Rectal Bleeding in Primary Care.”. Journal of General Internal Medicine 39 (6): 985-91.

Roblin, Xavier, Stéphane Nancey, Konstantinos Papamichael, Gérard Duru, Mathurin Flamand, Sandy Kwiatek, Adam Cheifetz, Nicole Fabien, Mathilde Barrau, and Stephane Paul. 2024. “Higher Serum Infliximab Concentrations Following Subcutaneous Dosing Are Associated With Deep Remission in Patients With Inflammatory Bowel Disease.”. Journal of Crohn’s & Colitis 18 (5): 679-85.

Ballou, Sarah, Prashant Singh, Judy Nee, Vikram Rangan, Johanna Iturrino, Grace Geeganage, Bernd Löwe, et al. 2023. “Prevalence and Associated Factors of Bloating: Results From the Rome Foundation Global Epidemiology Study.”. Gastroenterology 165 (3): 647-655.e4.

De Mello, Munique Kurtz, Natália Sousa Freitas Queiroz, and Konstantinos Papamichael. 2024. “Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22 (1): 200-201.

Flynn, Duncan J, and Joseph D Feuerstein. 2023. “In H Pylori Infection, Vonoprazan Plus High-Dose Amoxicillin Was Noninferior to B-Quadruple Therapy for Eradication.”. Annals of Internal Medicine 176 (5): JC54.

Cassavaugh, Jessica, Nada Qureshi, Eva Csizmadia, Maria Serena Longhi, Robina Matyal, and Simon C Robson. 2023. “Regulation of Hypoxic-Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury.”. Pharmaceuticals (Basel, Switzerland) 16 (3).

Rabinowitz, Loren G. 2023. “Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study.”. Inflammatory Bowel Diseases 29 (12): 2001-2.

Cheifetz, Adam S, Niels Vande Casteele, Zhongya Wang, Marla C Dubinsky, and Konstantinos Papamichael. 2023. “Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn’s Disease: A Post Hoc Analysis of the REACH Trial.”. The American Journal of Gastroenterology 118 (3): 485-90.

Said, Hyder, Judy Nee, Johanna Iturrino, Vikram Rangan, Prashant Singh, Anthony Lembo, and Sarah Ballou. 2023. “Clinical Characteristics of Patients Presenting With Bloating As a Predominant Symptom.”. Journal of Clinical Gastroenterology 57 (8): 830-34.

Papamichael, Konstantinos, Marla C Dubinsky, and Adam S Cheifetz. 2023. “Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn’s Disease.”. Gastroenterology 164 (1): 164-65.